Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma

Journal of Immunology

Volumn 178, Issue 12, 2007, Pages 7879-7889

  Ochkur, Sergei I ^a   Jacobsen, Elizabeth A ^a   Protheroe, Cheryl A ^a   Biechele, Travis L ^a   Pero, Ralph S ^a   McGarry, Michael P ^a   Wang, Huiying ^b   O'Neill, Katie R ^a   Colbert, Dana C ^a   Colby, Thomas V ^c   Shen, Huahao ^b   Blackburn, Michael R ^d   Irvin, Charles C ^e   Lee, James J ^a,c   Lee, Nancy A ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN; EOTAXIN 2; INTERLEUKIN 5; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCUS; CONTROLLED STUDY; DEGRANULATION; DESQUAMATION; DISEASE SEVERITY; EOSINOPHIL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYPERPLASIA; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TRANSGENIC MOUSE;

EID: 34250159031     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.12.7879     Document Type: Article

References (50)

1. Filley, W. V., G. M. Kephardt, L. E. Holley, and G. J. Gleich. 1982. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma, Lancet ii: 11-16.
2. Erjefält, J. S., M. Andersson, L. Greiff, M. Korsgren, M. Gizycki, P. K. Jeffery, and G. A. Persson. 1998. Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils. J. Allergy Clin. Immunol. 102: 286-294.
3. Erjefält, J. S., and C. G. Persson. 2000. New aspects of degranulation and fates of airway mucosal eosinophils. Am. J. Respir. Crit. Care Med. 161: 2074-2085.
4. Watt, A. P., B. C. Schock, and M. Ennis. 2005. Neutrophils and eosinophils: clinical implications of their appearance, presence and disappearance in asthma and COPD. Curr. Drug Targets Inflamm. Allergy 4: 415-423.
5. Stelts, D., R. W. Egan, A. Falcone, C. G. Garlisi, G. J. Gleich, W. Kreutner, T. T. Kung, D. K. Nahrebne, R. W. Chapman, and M. Minnicozzi. 1998. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation. Am. J. Respir. Cell Mol. Biol. 18: 9463-9470.
6. Flood-Page, P., A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, M. S. Ludwig, N. Barnes, D. Robinson, and A. B. Kay. 2003. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 112: 1029-1036.
7. Gleich, G. J., D. B. Jacoby, and A. D. Fryer. 1995. Eosinophil-associated inflammation in bronchial asthma: a connection to the nervous system. Int. Arch. Allergy Immunol. 107: 205-207.
8. Evans, C. M., A. D. Fryer, D. B. Jacoby, G. J. Gleich, and R. W. Costello. 1997. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J. Clin. Invest. 100: 2254-2262.
9. Kips, J. C., G. P. Anderson, J. J. Fredberg, U. Herz, M. D. Inman, M. Jordana, D. M. Kemeny, J. Lotvall, R. A. Pauwels, C. G. Plopper, et al. 2003. Murine models of asthma. Eur. Respir. J. 22: 374-382.
10. Shapiro, S. D. 2006. Animal models of asthma: pro: allergic avoidance of animal (model(s)) is not an option. Am. J. Respir. Crit. Care Med. 174: 1171-1173.
11. Wenzel, S., and S. T. Holgate. 2006. The mouse trap: it still yields few answers in asthma. Am. J. Respir. Crit. Care Med. 174: 1173-1176. discussion 1176-1178.
12. Denzler, K. L., S. C. Farmer, J. R. Crosby, M. T. Borchers, G. Cieslewicz, K. A. Larson, S. Cormier-Regard, N. A. Lee, and J. J. Lee. 2000. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J. Immunol. 165: 5509-5517.
13. Denzler, K. L., M. T. Borchers, J. R. Crosby, G. Cieslewicz, E. M. Hines, J. P. Justice, S. A. Cormier, K. A. Lindenberger, W. Song, W. Wu, et al. 2001. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J. Immunol. 167: 1672-1682.
14. Ying, S., D. S. Robinson, Q. Meng, L. T. Barata, A. R. McEuen, M. G. Buckley, A. F. Walls, P. W. Askenase, and A. B. Kay. 1999. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J. Immunol. 163: 3976-3984.
15. Komiya, A., H. Nagase, H. Yamada, T. Sekiya, M. Yamaguchi, Y. Sano, N. Hanai, A. Furuya, K. Ohta, K. Matsushima, et al. 2003. Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. Cell. Immunol. 225: 91-100.
16. Blanchard, C., N. Wang, K. F. Stringer, A. Mishra, P. C. Fulkerson, J. P. Abonia, S. C. Jameson, C. Kirby, M. R. Konikoff, M. H. Collins, et al. 2006. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116: 536-547.
17. Rothenherg, M. E. 1999. Eotaxin: an essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol. 21: 291-295.
18. Pope, S. M., P. C. Fulkerson, C. Blanchard, H. Saito Akei, N. M. Nikolaidis, N. Zimmermann, J. D. Molkentin, and M. E. Rothenherg. 2005. Identification of a cooperative mechanism involving IL-13 and cotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280: 13952-13961.
19. Pope, S. M., N. Zimmermann, K. F. Stringer, M. L. Karow, and M. E. Rothenberg. 2005. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J. Immunol. 175: 5341-5350.
20. Fujisawa, T., Y. Kato, H. Nagase, J. Atsuta, A. Terada, K. Iguchi, H. Kamiya, Y. Morita, M. Kitaura, H. Kawasaki, et al. 2000. Chemokines induce eosinophil degranulation through CCR-3. J. Allergy Clin. Immunol. 106: 507-513.
21. Mould, A. W., A. J. Ramsay, K. I. Matthaei, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2000. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity. J. Immunol. 164: 2142-2150.
22. Lee, J. J., M. P. McGarry, S. C. Farmer, K. L. Denzler, K. A. Larson, P. E. Carrigan, I. E. Brenneise, M. A. Horton, A. Haczku, E. W. Gelfand, et al. 1997. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J. Exp. Med. 185: 2143-2156.
23. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776.
24. Yang, M., S. P. Hogan, S. Mahalingam, S. M. Pope, N. Zimmermann, P. Fulkerson, L. A. Dent, I. G. Young, K. I. Matthaei, M. E. Rothenberg, and P. S. Foster. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy Clin. Immunol. 112:935-943.
25. Menzies-Gow, A., S. Ying, I. Sabroe, V. L. Stubbs, D. Soler, T. J. Williams, and A. B. Kay. 2002. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, hasophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J. Immunol. 160: 2712-2718.
26. Hackett, B. P., and J. D. Gitlin. 1992. Cell-specific expression of a Clara cell secretory protein-human growth hormone gene in the bronchiolar epithelium of transgenic mice. Proc. Natl. Acad. Sci. USA 89: 9079-9083.
27. Palmiter, R. D., E. P. Sandgren, M. R. Avarbock, D. D. Allen, and R. L. Brinster, 1991. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. USA 88: 478-482.
28. Lee, N. A., M. P. McGarry, K. A. Larson, M. A. Horton, A. B. Kristensen, and J. J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullar eosinophilopoiesis, and unique histopathologies. J. Immunol. 158: 1332-1344.
29. Shen, H. H., S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechele, K. R. O'Neill, T. L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170: 3296-3305.
30. Novak, E. K., M. Reddington, L. Zhen, P. E. Stenberg, C. W. Jackson, M. P. McGarry, and R. T. Swank. 1995. Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation. Blood 85: 1781-1789.
31. Tomioka, S., J. H. Bates, and C. G. Irvin. 2002. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J. Appl. Physiol. 93: 263-270.
32. Irvin, C. G., Y. P. Tu, J. R. Sheller, and C. D. Funk. 1997. 5-Lipoxygenase products are necessary for ovalbumin-induecd airway responsiveness in mice. Am. J. Physiol. 272: L1053-L1058.
33. Wang, H. Y., H. H. Shen, J. J. Lee, and N. A. Lee. 2006. CD69 expression on airway eosinophils and airway inflammation in a murine model of asthma. Chin. Med. J. 119: 1983-1990.
34. Hartnell, A., D. S. Robinson, A. B. Kay, and A. J. Wardlaw. 1993. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80: 281-286.
35. Rumbley, C. A., H. Sugaya, S. A. Zekavat, M. El Refaei, P. J. Perrin, and S. M. Phillips. 1999. Activated eosinophils are the major source of Th2-associated cytokines in the schistosome granuloma. J. Immunol. 162: 1003-1009.
36. Clark, K., L. Simson, N. Newcombe, A. M. Koskinen, J. Mattes, N. A. Lee, J. J. Lee, L. A. Dent, K. I. Matthaei, and P. S. Foster. 2004. Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J. Leukocyte Biol 75: 1001-1009.
37. Dvorak, A. M., and T. Ishizaka. 1994. Human eosinophils in vitro: an ultrastructural morphology primer. Histol. Histopathol. 9: 339-374.
38. Colby, T. V. 1998. Bronchiolitis: pathologic considerations. Am. J. Clin. Pathol. 109: 101-109.
39. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using harometric plethysmography. Am. J. Respir. Crit. Care. Med. 156: 766-775.
40. Malm-Erjefalt, M., T. R. Stevens, C. G. Persson, and J. S. Erjefalt. 2004. Discontinuous Percoll gradient centrifugation combined with immunomagnetic separation obviates the need for erythrocyte lysis and yields isolated eosinophils with minimal granule abnormalities. J. Immunol. Methods 288: 99-109.
41. Henderson, W. R., Jr., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E. Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit Care Med 165: 108-116.
42. Oliveira, S. H., D. D. Taub, J. Nagel, R. Smith, C. M. Hogaboam, A. Berlin, and N. W. Lukacs. 2002. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. Blood 100: 4291-4297.
43. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170.
44. Chibara, J., T. Yamamoto, H. Kayaba, T. Kakazu, D. Kurachi, J. Yamamoto, S. Iwasa, K. Iida, O. Urayama, and Y. Kobayashi. 1999. Degranulation of eosinophils mediated by intercellular adhesion molecule-1 and its ligands is involved in adhesion molecule expression on endothelial cells-selective induction of VCAM-1. J. Allergy Clin. Immunol. 103: S452-S456.
45. Pearce, N., J. Douwes, and R. Beasley. 2000. Is allergen exposure the major primary cause of asthma? Thorax 55: 424-431.
46. Elias, J. A., C. G. Lee, T. Zheng, B. Ma, R. J. Homer, and Z. Zhu. 2003. New insights into the pathogenesis of asthma. J. Clin. Invest. 111: 291-297.
47. Jarai, G., M. Sukkar, S. Garrett, N. Duroudier, J. Westwick, I. Adcock, and K. F. Chung. 2004. Effects of interleukin-1β, interleukin-13 and transforming growth factor-β on gene expression in human airway smooth muscle using gene microarrays. Eur. J. Pharmacol. 497: 255-265.
48. Kanaoka, Y., and J. A. Boyce. 2004. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173: 1503-1510.
49. Henderson, W. R., J. B. Harley, and A. S. Fauci. 1984. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. Immunology 51: 679-686.
50. Uchida, D. A., S. J. Ackerman, A. J. Coyle, G. L. Larsen, P. F. Weller, J. Freed, and C. G. Irvin. 1993. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo: a comparison with polycations. Am. Rev. Respir. Dis. 147: 982-988.